Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elanco Animal Health Incorporated Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.92 (market cap $11.26B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Elanco Animal Health Incorporated Common Stock and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| ELAN | HALO | |
|---|---|---|
Market Cap | $11.26B | $12.58B |
Volume | 4,570,386 | 2,179,278 |
Sector | Health | Health |
52-Week High | $26.84 | $115.22 |
52-Week Low | $19.76 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.65B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Elanco Animal Health Incorporated Common Stock
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
